QCi’s Stock and IBM’s Quantum Computing Strategy

QCi’s photonic chips appear promising, but there’s a consensus that their stock is quite overvalued.

IBM has been steadily enhancing its quantum computing division for the last decade or so.

Comparatively, IBM has a more balanced approach to quantum technology with better returns.

The company, closely identified as QCi, has been performing well since it transitioned from the over-the-counter market to the Nasdaq on July 15, 2021. Initially, shares were priced at $6.60, but they plummeted to a low of $0.42 by July 1, 2024. It’s interesting to see how, despite initial setbacks, market enthusiasm for quantum computing has lifted the stock to about $12. In fact, a $1,000 investment during its lowest point would now approach about $27,400. That’s quite a jump.

QCi made waves for its photonic quantum chips, which utilize light for data processing. They’re produced using traditional manufacturing methods and function at room temperature. This sets them apart from other types of quantum chips that often require complex cooling systems and are harder to produce.

In theory, these chips are supposed to be cheaper and easier to scale, but real-world application shows a different story. They tend to generate more errors and still rely on quite large optical systems, which makes them pricey for small-scale manufacturing.

Last May, QCi launched its first foundry and started shipping chips, but revenue primarily comes from service contracts and its cloud-based quantum computing platform, Dirac-3, rather than from chip sales directly.

Looking ahead, analysts project QCi will only make around $2.8 million by 2026. This sounds low against a market cap of $2.69 billion, indicating a hefty valuation of about 960 times that revenue estimate. Such a lofty valuation could be a red flag, especially for short sellers, once the market fluctuates.

It’s forecasted that by the end of 2025, about 22% of QCi’s shares could be sold short, possibly increasing as investors catch on to the fact that expanding its chip business could take years. Instead of getting caught up in QCi’s ups and downs, investors might be better served by focusing on more stable, dividend-yielding companies, like IBM.

IBM was once seen as a tech giant past its prime, with a significant decline in annual revenue from $106.9 billion in 2011 to $55.2 billion in 2020. They faced challenges in growing their core businesses, and instead of investing in innovation, they opted for aggressive cost-cutting and share buybacks.

However, everything shifted when Arvind Krishna became CEO in 2020. He guided a transformation by spinning off its underperforming managed infrastructure services division, Kyndryl, and bolstered Red Hat’s AI and hybrid cloud offerings. During the period from 2020 to 2024, IBM’s revenue and earnings per share did show growth, albeit modest at around 3% and 1%, respectively.

As IBM stabilizes its primary business, it’s also expanding its quantum computing sector, focusing on chips designed for precision and efficiency. They have deployed over 85 quantum systems and executed around 3 trillion programs. Several experimental chips are being developed, aiming for fully fault-tolerant systems by 2029.

IBM employs both smaller exploratory quantum systems and larger ones, primarily catering to academic and government research. Although the revenue from this sector isn’t significant yet, the company’s growth trajectory and ongoing advancements justify its current stock valuation, even at 30 times this year’s earnings. Plus, IBM has a solid track record of increasing dividends continuously over the past three decades, with a future yield projected at 2.3%.

While QCi and other quantum stocks garner more attention lately, IBM stands out as a potentially more appealing long-term investment. Its established presence in cloud and AI gives it a strategic edge in the emerging quantum computing landscape.

Before diving into quantum computing stocks, it’s worth pondering your options carefully.